November

Cornell startup, Metabolon, pushes metabolomics boundaries

Cornell startup Metabolon aims to launch a diagnostics business during the next 12-18 months. Metabolon has identified several biomarkers and owns the necessary IP or has patent applications covering both prostate cancer and insulin resistance.

The sale of Cornell startup, Kionix, for $233M to ROHM drives valuations in MEMS M&A in 2009

This may signal that the MEMS industry will undergo a new wave of consolidation to get into the MEMS industry as it enters in the mainstream markets.

Cornell startup, Widetronix, creates 25 year battery

Cornell startup Widetronix develops long-lived nuclear batteries powered by hydrogen isotopes for use in implantable medical devices.

October

New center to bring CU agricultural innovations to China

A new center may help make such Cornell agricultural advances as transgenic drought- and salt-tolerant rice available in China.

September

Fabrics that fight germs and detect explosives go to market

Cornell startup, iFyber, uses technology developed through a cross-campus collaboration by fiber science professor Juan Hinestroza and Aaron Strickland, a research associate in the Department of Food Science.

August

Mining the web for feelings, not facts

Cornell startup, Jodange, offers a service geared toward online publishers that lets them incorporate opinion data drawn from over 450,000 sources, including mainstream news sources, blogs and Twitter.

Cornell makes cancer vaccine for clinical use

The Bioproduction Facility at Cornell University has produced the first batch of NY-ESO-1 recombinant protein, a cancer vaccine that will be used in clinical trials for patients facing either ovarian cancer or melanoma.

Cornell startup, Novomer, raises $14M in new funding

Jim Mahoney, Novomer CEO, says the funding gives the company the cash it needs to ramp up its production process, buy raw materials, and design new products in conjunction with partners.

Researchers have created the tiniest laser since its invention nearly 50 years ago

Cornell's Materials Science and Engineering Department, the Birck Nanotechnology Center, and the Center for Materials Research at Norfolk State have created a nanolaser.

Cornell genome sequencing startup raises $68 million in new financing

Cornell startup, Pacific BioSciences, one of the companies working to advance DNA sequencing technology, brought in $68M in new financing.

July

Exploring collaboration opportunities in sustainable development (story is in Chinese only)

Cornell Vice Provost, Alan Paau, was received by official of the Hainan Chengjiang Li Minority Autonomous Region in Hainan Island to explore collaboration opportunities in sustainable development for the area. Hainan Island is the second largest island in China. The island is the largest island of the Nansha (Spratly) and the Xisha (Paracel) archipelagos in South China Sea that represent the southern-most province of the country.

Exploring collaboration opportunities in agriculture commercialization

Chinese Minister of Agriculture, Sun Zhencai, received Cornell Vice Provost, Alan Paau, at the Chinese Ministry of Agriculture in Beijing, China to explore collaboration opportunities in agriculture technology development and commercialization.

June

Molecule-size capsules can deliver drugs by sticking to targeted cells

It is now possible to engineer tiny containers the size of a virus to deliver drugs and other materials to targeted cells in the bloodstream.

April

Cornell startup, Widetronix, wins New York Creative Core Emerging Business Competition

Cornell startup, Widetronix, beats 76 companies to win $100,000 cash prize.

Cornell University working on low-power memory

Research at Cornell University could lead to low-power, high-efficiency memory chips.

New Biomarker for prostate cancer

A newly discovered gene fusion may lead to more accurate tests for prostate cancer.

New method to produce critical proteins without using live cells

A new method developed by Cornell biological engineers offers an efficient way to make proteins for use in medicine or industry without the use of live cells.

March

World's first nanoscale fluidic (nanofluidic) device with complex 3-D surfaces.

A novel device developed by Cornell researchers has a geometry that allows it to manipulate nanoparticles by size.

New test may predict breast cancer metastasis

Researchers at Weill Cornell Medical College have identified a new marker for breast cancer metastasis called TMEM, for Tumor Microenvironment of Metastasis.

February

Cornell researchers develop artificial artery

Cornell fiber scientist C.C. Chu and his collaborators develop a high-functioning artificial artery that the human body will accept as its own.

Cornell researchers use cotton candy to create new blood-flow routes

Physicians and scientists from New York-Presbyterian Hospital/Weill Cornell Medical College and the Ithaca campus may have developed a way to create engineered tissue that is well accepted by the body.

Researcher details role of apples in inhibiting breast cancer

Studies by Rui Hai Liu support growing evidence that apple phytochemicals inhibit the growth of mammary tumors.

January

Cornell signs grape research and licensing venture with Sun World International

Cornell and Sun World operate two of the world's leading fresh grape breeding programs.